Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004969576 | SCV005525469 | uncertain significance | Inborn genetic diseases | 2024-08-02 | criteria provided, single submitter | clinical testing | The c.252G>C (p.Q84H) alteration is located in exon 1 (coding exon 1) of the TTI2 gene. This alteration results from a G to C substitution at nucleotide position 252, causing the glutamine (Q) at amino acid position 84 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |